BioSpace News Archive

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announces that the Company will host its earnings conference call on Tuesday, April 20, 2021 at 8:00 am Eastern Time (5:00 am Pacific Time/ 8:00 pm Beijing Time) to discuss the Company’s financial results of the fourth quarter and fiscal year ended December 31, 2020.

Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will present and host one-on-one investor meetings at the upcoming 20th Annual Needham Virtual Healthcare Conference

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points

Applied UV, Inc. (NASDAQ:AUVI) , an infection control technology company that applies the power of narrow-range ultraviolet light for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will host an investor conference call and live webcast to discuss its results on Wednesday March 31 2021

Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group, has appointed Martin Marciniak, RPh, MPP, PhD, as Vice President of Medical Affairs to progress the company’s therapeutic area efforts.

Hollister Incorporated, a global medical device company and US market share leader in Ostomy care has been awarded a contract for ostomy products with Vizient, Inc.

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide the latest update on the Company’s regulatory filing preparation activities. The Company expects to file for approval for its first in class BPH treatment Fexapotide Triflutate, during the summer of this year

Each year the National Kidney Foundation considers the work of hundreds of specialists in the field of nephrology and selects among them those who most exemplify the relentless efforts of NKF to enhance the lives of patients through action, education, and accelerating change.

Abbott will announce its first-quarter 2021 financial results on Tuesday, April 20, 2021, before the market opens.

Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced full year 2020 financial results and provided an update on recent progress.